But now the factory is almost fully restored to pre-hurricane production levels. "We continue to make strong progress at ...

I critique Baxter International's capital allocation decisions, stating the stock is not suitable for popular investment strategies. See why I rate BAX a sell.

Baxter stock tumbled Tuesday, undercutting its 50-day line, after the medtech company agreed to sell its kidney segment to Carlyle for $3.8 billion. Please watch the video at Investors.com - How ...

Baxter International has agreed to sell its kidney treatment division to private equity firm Carlyle Group in a $3.8 billion cash deal, continuing its efforts to streamline its operations and ...

Baxter International Inc. (BAX), headquartered in Deerfield, Illinois, is a healthcare leader committed to transforming lives ...

Baxter International has increased allocations for two U.S. IV solutions to 100% following the disruption caused by Hurricane Helene at its North Cove, N.C., facility, according to a letter to ...

Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion ...

A follow-up to Baxter’s communication on December 13, 2024 regarding increases in allocations for several U.S. IV products, ...

Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its fourth-quarter 2024 financial results on Thursday, February 13, 2025 at 7:30 a.m. Central Time ...

The company, a major provider of fluids used for home dialysis, is aiming to “restore ... units will be imported over the coming weeks as Baxter and federal agencies try to keep hospitals ...

Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we’ve been operating at ...